About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 1NCT00548197

Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment

Vitreoretinal surgery for epiretinal proliferation tractional retinal detachment associated with proliferative diabetic retinopathy (PDR) is often complicated by hemorrhage from fibrovascular tissue. ...

Lead sponsor: Iran University of Medical Sciences•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Iran University of Medical Sciences

Eligibility criteria: Diabetic tractional retinal detachment-complexity score between 4 and 8 Main outcome measures: best corrected visual acuity-anatomic condition of the retine(re-attachment of the retina)

Age

18 - 90 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Those patients with tractional retinal detachment who are candidated for pars plana vitrectomy.
•Complexity score between 4 and 8.

Exclusion Criteria

•Previous vitreoretinal surgery.
•Presence of any other vitreoretinal pathology such as past or present uveitis, and retinal artery or vein occlusion.

Related studies

Necessity of Post-operative Eye Drops

NCT07396831 · Pars Plana Vitrectomy, Scleral Buckling, and more

Not Yet RecruitingNA

INTRAOCULAR PRESSURE MEASUREMENT AT the END of PARS PLANA VITRECTOMY

NCT06707168 · Pars Plana Vitrectomy

Assessment of Retinal Vascular Changes With and Without ILM Peeling in Diabetic Vitrectomy Using OCT-A.

NCT05739539 · Diabetic Vitreous Hemorrhage, Tractional Retinal Detachment

Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled Trial

NCT05990829 · Diabetic Macular Edema, Pars Plana Vitrectomy, and more

Establishment and Validation of a Risk Prediction Model for Long-term Low Vision After Vitrectomy in PDR Patients

NCT05631054 · Proliferative Diabetic Retinopathy, Pars Plana Vitrectomy, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 16, 2018Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment40

Start dateFeb 2007

Last updatedOct 16, 2018

Condition

Intravitreal Bevacizumab Injection Pars Plana Vitrectomy Tractional Retinal Detachment Diabetic Retinopathy

Locations shown

Rasool Akram Hospital

Tehran

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 16, 2018Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions